Volume | 284,847 |
|
|||||
News | - | ||||||
Day High | 11.75 | Low High |
|||||
Day Low | 11.26 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Nevro Corp | NVRO | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
11.55 | 11.26 | 11.75 | 11.32 | 11.62 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
4,027 | 284,847 | US$ 11.41 | US$ 3,250,169 | - | 11.26 - 34.86 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:59:05 | 1 | US$ 11.31 | USD |
Nevro Corp Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
412.39M | 36.40M | - | 425.17M | -92.21M | -2.53 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Nevro News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVRO Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 12.30 | 13.30 | 11.26 | 12.29 | 446,632 | -0.98 | -7.97% |
1 Month | 14.43 | 14.44 | 11.26 | 12.77 | 428,418 | -3.11 | -21.55% |
3 Months | 16.97 | 17.75 | 11.26 | 14.54 | 452,737 | -5.65 | -33.29% |
6 Months | 15.33 | 22.64 | 11.26 | 16.74 | 537,985 | -4.01 | -26.16% |
1 Year | 32.52 | 34.86 | 11.26 | 19.72 | 532,522 | -21.20 | -65.19% |
3 Years | 166.37 | 182.45 | 11.26 | 55.46 | 545,187 | -155.05 | -93.20% |
5 Years | 62.41 | 188.14 | 11.26 | 75.96 | 489,325 | -51.09 | -81.86% |
Nevro Description
Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany. |